Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 3 Results

Intervention Indication Therapeutic Area Year Actions
Clostridium botulinum type A toxin-haemagglutinin complex (Dysport) for urinary incontinence Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607) Neurogenic detrusor overactivity , Urinary incontinence Neurology , Urology 2021 View  |  Download
Mirabegron for neurogenic detrusor overactivity in people aged 3 to 17 years Mirabegron Neurogenic detrusor overactivity Neurology , Urology 2022 View  |  Download
Oxybutynin hydrochloride for treating neurogenic detrusor overactivity Oxybutynin hydrochloride (Vesoxx) Neurogenic detrusor overactivity Neurology , Urology 2022 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications